← back to search

Klaus‐Dieter Riedel

University Hospital Heidelberg · DE
Area of research
Pharmacology · Infectious Diseases
Research interest
Research interests include Efavirenz, Genotype, Ethnic group, CYP2B6, Pharmacokinetics, and Medicine.
h-index
citations
185
works
2
NIH funding
primary concept
email

Recent publications

Importance of Ethnicity, CYP2B6 and ABCB1 Genotype for Efavirenz Pharmacokinetics and Treatment Outcomes: A Parallel-Group Prospective Cohort Study in Two Sub-Saharan Africa Populations
PLoS ONE 2013cited by 124position: middledoi
Liver Enzyme Abnormalities and Associated Risk Factors in HIV Patients on Efavirenz-Based HAART with or without Tuberculosis Co-Infection in Tanzania
PLoS ONE 2012cited by 61position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Eliford Ngaimisi · University of Maryland, Baltimore2 papers (2012–2013)Jürgen Burhenne · Columbus Oncology and Hematology Associates2 papers (2012–2013)Eleni Aklillu · Karolinska University Hospital2 papers (2012–2013)Sabina Mugusi · Muhimbili University of Health and Allied Sciences2 papers (2012–2013) · 2 papers (2012–2013) · 2 papers (2012–2013)Leif Bertilsson · Karolinska University Hospital1 papers (2013–2013)Muhammad Bakari · University of Arizona1 papers (2012–2012)Abiy Habtewold · William Carey University1 papers (2013–2013) · 1 papers (2013–2013) · 1 papers (2012–2012)Wondwossen Amogne · Addis Ababa University1 papers (2013–2013)Eric Sandström · Science for Life Laboratory1 papers (2012–2012)Lars Lindquist · Karolinska Institutet1 papers (2012–2012) · 1 papers (2013–2013)Getnet Yimer · The Ohio State University1 papers (2013–2013) · 1 papers (2013–2013)